V. G. Devries

发表

CL 277,082: a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption.

S. A. Schaffer, E. Largis, C. H. Wang, 1989, Journal of lipid research.

Potential antiatherosclerotic agents. 2. (Aralkylamino)- and (alkylamino) benzoic acid analogues of cetaben.

M. Reich, S. A. Schaffer, J. D. Albright, 1983, Journal of medicinal chemistry.

Potential antiatherosclerotic agents. 3. Substituted benzoic and non benzoic acid analogues of cetaben.

M. Reich, J. D. Albright, E. Largis, 1983, Journal of medicinal chemistry.

Potential antiatherosclerotic agents. 6. Hypocholesterolemic trisubstituted urea analogues.

M. Dutia, A. Katocs, J. Bloom, 1989, Journal of Medicinal Chemistry.

Potential antiatherosclerotic agents. 5. An acyl-CoA:cholesterol O-acyltransferase inhibitor with hypocholesterolemic activity.

M. Dutia, A. Katocs, J. Bloom, 1986, Journal of medicinal chemistry.

Safety profile of piperacillin/tazobactam in phase I and III clinical studies.

C. A. Morrow, F. Tally, J. Teal, 1993, The Journal of antimicrobial chemotherapy.

Hypolipidemic alkoxybenzoic acids.

S. J. Riggi, V. G. Devries, D. Moran, 1976, Journal of medicinal chemistry.

Potential antiatherosclerotic agents. 4. [(Functionalized-alkyl)amino]benzoic acid analogues of cetaben.

E. Largis, J. Upeslacis, V. G. Devries, 1983, Journal of medicinal chemistry.

Alkylation of a,-Unsaturated Ketones with Polymethylene Dibromides

M. Newman, V. G. Devries, R. S. Darlak, 1966 .